Work

Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells

Year: 2011

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-011-1150-z

Authors: Tracy R. Daniels, Richard K. Leuchter, Rafaela Quintero, Gustavo Helguera, José A. Rodríguez, Otoniel Martínez-Maza, Birgit C. Schultes, Christopher F. Nicodemus, Manuel L. Penichet

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Momenta Pharmaceuticals (United States), Advanced Immune Therapeutics (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Consejo Nacional de Investigaciones Científicas y Técnicas, Consejo Nacional para Investigaciones Científicas y Tecnológicas, National Institutes of Health, Center for AIDS Research, University of Washington, Agencia Nacional de Promoción Científica y Tecnológica, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Jonsson Comprehensive Cancer Center, UCLA AIDS Institute, Fondo Argentino Sectorial

Awards: G1312273583, G1338448323, G1373914732, G1543282891, G1601898348, G2567196567, Immune Dysfunction and AIDS-associated B Cell Lymphoma, Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL, G4348962262, G4925148195, G5331288106, G632876785, G7378882120, UCLA Center for AIDS Research (CFAR), G9000075819, G9000090879, G9000126127, G9000286139, Cancer Center Support Grant

OpenAlex ID: W1971977282

FWCI: 1.149

Cites: 77

Cited by: 45

Related to: 10